ask="0.6290"
ask_size="1100"
average_daily_volume="153885"
bid="0.5500"
bid_size="1000"
book_value="0.7250"
change="+0.0001"
change_from_200_day_moving_average="-0.6739"
change_from_50_day_moving_average="-0.3244"
change_from_52_week_high="-1.3801"
change_From_52_week_low="0.0599"
change_in_percent="+0.0161%"
close="0.6199"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.9300"
eps_estimate_next_quarter="-0.2300"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.6290"
high_52_weeks="2.0000"
last_trade_date="3/9/2017"
last_trade_price="0.6199"
last_trade_size="485"
last_trade_time="4:00pm"
low="0.5880"
low_52_weeks="0.5600"
market_capitalization="23.96M"
moving_average_200_day="1.2938"
moving_average_50_day="0.9443"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="0.6200"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-52.0858%"
percent_change_from_50_day_moving_average="-34.3525%"
percent_change_from_52_week_high="-69.0050%"
percent_change_from_52_week_low="+10.6964%"
previous_close="0.6198"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8549"
price_per_sales="2.4444"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="0.3800"
stock_exchange="NMS"
symbol="AVIR"
volume="34615"
weeks_range_52="0.5600 - 2.0000"
